According to reports, more than 65 crypto firms and advocacy groups have sent a joint letter to US President Donald Trump urging immediate action to clarify tax and regulatory rules for digital assets. Related Reading: Bitcoin To $220K In 45 Days? Genius Makes Bold Claim, Promises To Build Churches Worldwide The groups said agencies can […]According to reports, more than 65 crypto firms and advocacy groups have sent a joint letter to US President Donald Trump urging immediate action to clarify tax and regulatory rules for digital assets. Related Reading: Bitcoin To $220K In 45 Days? Genius Makes Bold Claim, Promises To Build Churches Worldwide The groups said agencies can […]

Over 65 Crypto Firms Unite In Letter To Trump: Lead Or Fall Behind

2025/11/22 15:00
3 min read

According to reports, more than 65 crypto firms and advocacy groups have sent a joint letter to US President Donald Trump urging immediate action to clarify tax and regulatory rules for digital assets.

The groups said agencies can move now to protect US innovation without waiting for Congress, and they laid out a set of specific fixes they want applied quickly.

The letter was signed by some of the biggest names in the blockchain and crypto industry, including Coinbase, Uniswap Labs, Exodus, Pantera, the Blockchain Association, the Solana Foundation, and the Solana Policy Institute, which helped lead the effort.

Reports also say other groups such as Block, Paradigm, Multicoin Capital, and the Crypto Council for Innovation joined the call for immediate action.

Tax Rules And Developer Protections

The letter asks for clearer tax treatment for everyday crypto activity, including a call to treat staking and mining rewards as self-created property that would be taxed only when sold or converted, not when received.

The groups also proposed a “de minimis” carve-out — an example figure mentioned in coverage was $600 — to avoid taxing tiny transfers that users don’t think of as taxable events.

The signers want rules that say routine operations like bridges, forks, airdrops, collateral moves, and liquidations should not automatically trigger tax events.

Regulators Urged To Move First

Industry leaders told the White House that agencies such as the SEC, CFTC, Treasury and DOJ can grant interim guidance, “no-action” letters, or exemptive relief to give builders room to work.

Reports say the groups pressed for targeted safe harbors and regulatory sandboxes to protect developers who publish open source code and to support self-custody options for everyday users. The push is framed as a short-term administrative fix while longer rulemaking proceeds.

A Call Over A High-Profile Case

The coalition also asked the administration to urge the Department of Justice to drop or reconsider charges against Roman Storm, the developer tied to Tornado Cash, arguing that his work should be treated as publishing software rather than a criminal act.

That request reflects broader industry concern about cases that, they say, blur the line between building code and committing a crime.

Where This Fits In The White House Agenda

The letter lands in the context of an executive push on crypto that began with an order signed on January 23, 2025, which set up a Presidential Working Group on Digital Asset Markets to coordinate a whole-of-government approach.

The industry frames the new letter as a practical follow-up: these are steps agencies could take now to make the rules clearer while the working group’s longer reports and proposals move forward.

Featured image from CP Image/Policy Options, chart from TradingView

Market Opportunity
Unite Logo
Unite Price(UNITE)
$0.00009742
$0.00009742$0.00009742
-0.11%
USD
Unite (UNITE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26